This just my opinion but if they DONT have a pen ready for marketing or extremely close then they are being very short sighted. Another reason it would be smart to have two pens or perhaps more with minor deviations. What is the compromise is fine you can make generic pens BUT the design has to be IDENTICAL to the Pfizer one? Or if they dont make that stipulation and AIS has a better design BAM we get to show the market how we can improve on the pen and do better than big bad Pfizer :)
They must have a pen ready to go to market based on the '012 patent case dismissal. Just waiting for FDA approval.
And why not another pen based on or one that addresses the '432 patent litigation.
After all, Meridian has two pens.
Now back to what's the most important topic - unsubstantiated rumors and personality clashes.
Did you hear the rumor that I'm going to bid on Antares? I just have to find the capital - a minor issue and hurdle to get over. Look for a future/new SEC 13G/A filing for the "KouJabTapDelRyDaug Yahoo Board Capital Fund" for a majority share stock purchase.
Disclosure: I just made that up folks. Happy Friday and a good weekend.